상단메뉴 바로가기 본문 바로가기 본문 하위메뉴 바로가기 하단 바로가기

News

HOMENews

News

LyseNTech completed MTA and CDA with Y-Biologics

관리자   /   2020-04-27

Sep 10, 2019 

 

LyseNTech completed MTA and CDA with Y-Biologics to develop advanced anticancer phage technology.

Y-Biologics is a Korean biotech company focusing on the discovery & development of novel antibody therapeutics based on its human antibody library and Bi-specific antibody platform technology.